Wikidata

(Q66037091)

English

"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

short name
REDUCE (English)
0 references
title
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Dutasteride 0.5 mg Administered Orally Once Daily for Four Years to Reduce the Risk of Biopsy-Detectable Prostate Cancer (English)
0 references
sponsor
GSK
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Belarus
0 references
Belgium
0 references
Brazil
0 references
Bulgaria
0 references
Canada
0 references
Chile
0 references
Croatia
0 references
Denmark
0 references
Estonia
0 references
Finland
0 references
France
0 references
Germany
0 references
Greece
0 references
Hungary
0 references
Ireland
0 references
Italy
0 references
Japan
0 references
Latvia
0 references
Lithuania
0 references
Mexico
0 references
Netherlands
0 references
New Zealand
0 references
Norway
0 references
Poland
0 references
Portugal
0 references
Romania
0 references
Slovakia
0 references
Slovenia
0 references
South Africa
0 references
Spain
0 references
Sweden
0 references
Switzerland
0 references
Tunisia
0 references
Turkey
0 references
Ukraine
0 references
United Kingdom
0 references
start time
March 2003
0 references
end time
January 2009
0 references
number of participants
8,231
0 references
research site
GSK
0 references
minimum age
50 year
0 references
maximum age
75 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q66037091&oldid=2153274822"